|
|
|
Volumn 2, Issue 8, 2004, Pages 527-532
|
|
Dihydropyrimidine dehydrogenase deficiency: impact of pharmacogenetics on 5-fluorouracil therapy.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5-FLUOROURIDINE 5'-TRIPHOSPHATE;
ANTIDOTE;
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYURIDINE PHOSPHATE;
DIHYDROPYRIMIDINE DEHYDROGENASE;
DRUG DERIVATIVE;
FLOXURIDINE;
FLUORODEOXYURIDINE TRIPHOSPHATE;
FLUOROURACIL;
FLUOROURIDINE TRIPHOSPHATE;
PRODRUG;
PYRIMIDINE NUCLEOSIDE;
THYMIDYLATE SYNTHASE;
URIDINE TRIPHOSPHATE;
BIOTRANSFORMATION;
CHEMICALLY INDUCED DISORDER;
DIARRHEA;
DRUG DETOXIFICATION;
DRUG ERUPTION;
FEVER;
GENETICS;
HUMAN;
MASS SCREENING;
METABOLISM;
MUCOSA INFLAMMATION;
MUTATION;
NUCLEOTIDE SEQUENCE;
REVIEW;
ANTIDOTES;
ANTIMETABOLITES, ANTINEOPLASTIC;
BIOTRANSFORMATION;
DEOXYURACIL NUCLEOTIDES;
DIARRHEA;
DIHYDROURACIL DEHYDROGENASE (NADP);
DNA MUTATIONAL ANALYSIS;
DRUG ERUPTIONS;
FEVER;
FLOXURIDINE;
FLUOROURACIL;
HUMANS;
MASS SCREENING;
METABOLIC DETOXICATION, DRUG;
MUCOSITIS;
MUTATION;
PRODRUGS;
PYRIMIDINE NUCLEOSIDES;
THYMIDYLATE SYNTHASE;
URIDINE TRIPHOSPHATE;
|
|
EID: 33747169515
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (51)
|
|
References (51)
|
